Showing posts with label vergote. Show all posts
Showing posts with label vergote. Show all posts
Tuesday, September 14, 2010
Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists? Vergote I, Amant F, L
Note: Dr Vergote is one of Europe's top gynecologic cancer researchers; journal correspondence=pay-per-view ($$$)
Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists?
Vergote I, Amant F, Leunen K.
Subscribe to:
Posts
(
Atom
)
